Aligos Therapeutics, Inc. ( ALGS) - Stock Earnings
ALGS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ALGS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.9 million USD | 169000 USD |
| 2026Q1 | -23.0 million USD | 2.8 million USD |
| 2026Q2 | -1.5 million USD | 27.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ALGS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -87.7 million USD | 15.5 million USD |
| 2024 | -131.2 million USD | 3.9 million USD |
| 2025 | -24.2 million USD | 2.2 million USD |
| 2026 Est. | — | — |
ALGS
Price: $5.23
52 week price:
Earnings Per Share: -7.43 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 78576
Market Capitalization: 34.3 million